French biotech developing functional precision medicine technology for cancer care
French biotech developing functional precision medicine technology for cancer care. Its platform uses patient-derived tumor biopsies, miniaturized tumor-on-chip/microfluidic systems, and AI-driven imaging to test drug responses and provide treatment insights for clinical decision-making and pharmaceutical drug development.